$3.6B/year Atkins of yogurt

TL;DR: Founded by Turkish immigrant dairy farmer Hamdi Ulukaya who bought a defunct Kraft yogurt plant with an SBA loan in 2005, Chobani popularized Greek yogurt and is now assembling a multi-category food & beverage platform through acquisitions of La Colombe ($900M) and Daily Harvest. Sacra estimates Chobani hit $3.6B in TTM revenue in September 2025, up ~22% YoY, valued at $20B after a $650M equity round in October 2025. For more, check out our full report and dataset on Chobani.

Key points from our research via Sacra AI:

Dannon (founded 1919) introduced fruit-on-the-bottom yogurt cups in the U.S in 1947, popularizing the immigrant health food by turning it into a sweetened snack product—a format that would hold until Turkish immigrant Hamdi Ulukaya bought a defunct Kraft plant on an SBA loan and launched Chobani (2007), capitalizing on a health-driven backlash against sugar with Greek yogurt which has 2x the protein per serving of regular yogurt. Repositioning yogurt from a cheap, dessert-like snack to a premium everyday source of protein like eggs or chicken breast, Chobani drove the growth of the Greek yogurt market from less than 1% of the U.S. yogurt market in 2007 to more than 50% by 2017, forcing competitive responses from Dannon (launching Oikos), Fage, and Lactalis (acquiring Siggi's).
Expanding from Greek yogurt into a five-category portfolio via Chobani oat milk (2019) & creamer (2019) and by acquiring cold brew brand La Colombe for $900M (2023) & DTC frozen meals brand Daily Harvest for $600M (2025), Sacra estimates Chobani hit $3.6B in TTM revenue in September 2025, up ~22% YoY, accelerating from 17% growth in 2024, valued at $20B after a $650M equity investment in October 2025 for a ~5.6x revenue multiple. Compare to direct yogurt competitor Dannon (EPA: BN) at ~$29.7B in revenue growing ~4% YoY trading at ~1.5x revenue, protein snack incumbent & Quest parent Simply Good Foods (NYSE: SMPL) at ~$1.4B revenue growing 7% YoY valued at $1.49B for a ~1x multiple, and plant-based oat milk company Oatly (NASDAQ: OTLY) at $863M in 2025 revenue, up ~5% YoY, trading at ~0.4x revenue after its market cap collapsed 95% from its 2021 IPO peak.
With ~12% of American adults reporting they've used a medication like Ozempic, the Chobani family of products has emerged as a perfect fit for the GLP-1 dietary spec, with Greek yogurt for protein density needed to preserve lean mass, La Colombe cold brew & creamer for the GLP-1 fatigue, and Daily Harvest frozen smoothies and bowls for the fiber needed to manage the gastrointestinal symptoms. Where GLP-1-era protein bar brand David is built around the engineered fat substitute EPG and markets it as core to their product, and Legendary Foods licenses it, Chobani positions itself as the natural option, delivering high protein density without the ingredient complexity or GI side-effect risk.

For more, check out this other research from our platform:

$3.6B/year Atkins of yogurt

Read more from

Chobani

Chobani revenue, growth, and valuation

Read more from
#b2c

$1B/year Finnish MAHA wearable

$180M/year protein poptart

Whop at $142M revenue

Create a free account, or log in.

Free article limit reached.

Standard membership required.